Paragon Care Limited (FRA:PXS)

Market Cap	275.19M
Revenue (ttm)	2.02B
Net Income (ttm)	11.49M
Shares Out	n/a
EPS (ttm)	0.01
PE Ratio	23.96
Forward PE	14.23
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.1560
Previous Close	0.1550
Day's Range	0.1560 - 0.1560
52-Week Range	0.1340 - 0.3240
Beta	n/a
RSI	44.92
Earnings Date	Nov 25, 2025

About Paragon Care

Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provides neonatal and paediatric assessment, including newborn hearing and vision screening, jaundice management, NICU video monitoring, brain monitoring, b...

• Industry: Specialty Cleaning, Polishing, and Sanitation Preparations
• CEO: Carmen Riley
• Employees: 550
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PXS

Financial Performance

In 2025, Paragon Care's revenue was 3.61 billion, an increase of 21.68% compared to the previous year's 2.97 billion. Earnings were 20.57 million, an increase of 151.52%.

Financial numbers in AUD